Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...

(Reuters) -OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other ...

Novo Nordisk owns two of them ... for when it gets FDA approval to sell VK2735 in pill form. Viking told investors that this agreement "provides Viking with sufficient long-term supply of both ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Conclave explores obesity as a metabolic disease, the role of medication like Ozempic, and holistic weight loss strategies, ...

German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...